GlucoSet

Norway
Trondhjem, Sor-Trondelag, Norway, 7037

Company profile

GlucoSet company profile

GlucoSet is medical device company that is developing sensor technology for improved glucose control in intensive care units. Blood glucose levels are elevated and unstable in hospital intensive care unit (ICU) patients. This leads to costly infections, increased length of stay and mortality. The GlucoSet intravascular sensor delivers continuous and accurate information on patient's blood glucose level, enabling normalization of glucose levels, without the risk of sudden and dangerously low glucose levels.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
2011-12-21

Headquarters

Postal code
7037
Country code
NO
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
7
Total equity funding
$6.7M
Last funding
Series A / $6.6M / 2023-07-07
Last equity funding
Series A / $6.6M
Investors
6
Lead investors
5
Founders
3
Articles
4

Founders and investors

Founders

Dag Roar HjelmeNicolas ElvemoReinold Ellingsen

Lead investors

European Innovation CouncilHorizon 2020Nordic Angel ProgramSwiss Diabetes Venture FundTeleVenture Management

Investors

EISMEAEuropean Innovation CouncilHorizon 2020Swiss Diabetes Venture FundTeleVenture Management